Lv2
128 积分 2025-11-30 加入
Endothelin Receptor Antagonist Ambrisentan, Sodium-Glucose Cotransporter 2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy
7小时前
求助中
Treatment of IgA Nephropathy with ACE Inhibitors
2天前
已完结
SERPINB10 promotes neutrophilic airway inflammation in asthma
29天前
已完结
Meta-Analysis of Randomized Controlled Trials Assessing the Efficacy and Safety of Endothelin Receptor Antagonists in CKD
1个月前
已关闭
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
2个月前
已完结
IgA Nephropathy in Adults
2个月前
已完结
Endothelin Receptor Antagonist Ambrisentan, SGLT2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy
2个月前
已关闭
Endothelin Receptor Antagonist Ambrisentan, SGLT2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy
2个月前
已关闭
Ambrisentan as adjunctive therapy for IgA nephropathy: a retrospective single-center analysis
2个月前
已完结
皖公网安备34019202002308
